The Vicious Cycle of Chronic Congestive Heart Failure









































- Slides: 41
The Vicious Cycle of Chronic Congestive Heart Failure
Spironolactone
Overflow and Underfilling Hypotheses of Sodium and Water Retention in Cirrhosis
PERIPHERAL ARTERIAL VASODILATION HYPOTHESIS COMPENSATED CIRRHOSIS (No Ascites) Peripheral Arterial Vasodilation Plasma Hormones (AVP, Renin, Aldosterone, NE) Plasma Volume Normal DECOMPENSATED CIRRHOSIS (Ascites) Hepatorenal Syndrome
Hypothalamic AVP-m. RNA of Control and Cirrhotic Rats
“I have ascites and have desire for water, Although I know this water will kill me. ” Rami (1226 -1294 A. D. )
Effects of Non-Peptide AVP Antagonist in Liver Cirrhosis
Effect of V 1 -Vasopressin Antagonist on Arterial Blood Pressure in Experimental Cirrhosis in Rats
ALDOSTERONE ANTAGONISM PROMOTES WEIGHT LOSS AND DISAPPEARANCE OF ASCITES IN DECOMPENSATED CIRRHOSIS PARAMETER CIRRHOTIC PATIENTS CONTROL (n-22) SPIRONOLACTONE (n=21) 7 5 Weight loss (lb) 6+2 24 + 4 Disappearance of ascites 4 16 Death Gregory et al. , 1977
Increased Distal Tubular Sodium Delivery with Mannitol Resulted in a Marked Natriuresis During ANP Infusion
Urinary c. GMP Increased Significantly During ANP and ANP + Mannitol
Distal Sodium Delivery During Mannitol and ANP + Mannitol in Cirrhotic Patients
Mean Arterial Pressure is Increased by Immersion Plus Norepinephrine but not by Immersion Alone
Effect of Increased Arterial Circulatory Integrity to Normalize Renal Water Excretion in Decompensated Cirrhotic Patients
Correlation Between Increase in Systemic Vascular Resistance and an Increase in Water Excretion in Cirrhotic Patients
Effects of Terlipressin and Albumin on Renal Function in Hepatrorenal Syndrome
Cirrhosis – Arterial Underfilling – Ascites
Effect of Chronic NOS Inhibition on Systemic Vascular Resistance in Cirrhotic Rats with Ascites
Effect of NOS Inhibition for 7 Days on e. NOS Protein Expression in Aortas and Mesenteric Arteries in Cirrhotic Rats with Ascites
Effect of Chronic NO Synthesis Inhibition on Aortic c. GMP in Cirrhotic Rats with Ascites
Effect of NOS Inhibition for 7 Days on Plasma Arginine Vasopressin and Atrial Natriuretic Peptide in Cirrhotic Rats with Ascites
Effect of NOS Inhibition for 7 Days on Water Excretion in Cirrhotic Rats with Ascites
Effect of NOS Inhibition for 7 Days on Plasma Renin Activity and Aldosterone in Cirrhotic Rats with Ascites
Sodium Excretion is Increased by Chronic L-Name Treatment in Cirrhotic Rats
Changes in Systemic Hemodynamic s and Plasma Volume During Pregnancy
Chronic L-NAME Treatment in Day 14 Pregnant Rats Returns Cardiac Output and SVR to Nonpregnant Levels
Chronic L-NAME Treatment in Day 14 Pregnant Rats Returns GFR and RPF to Nonpregnant Levels
Protein Expression of AQP 2 in Pregnancy
Effect of Vehicle and V 2 Antagonist on Water Balance in Pregnant Rats
PATHOPHYSIOLOGY OF WATER METABOLISM IN EDEMATOUS DISORDERS CONGESTIVE CARDIAC FAILURE CIRRHOSIS PREGNANCY Nitric Oxide CARDIAC OUTPUT PERIPHERAL VASODILATION V 2 RECEPTOR ANTAGONIST NON-OSMOTIC VASOPRESSIN RELEASE VASOPRESSIN V 2 RECEPTOR AQUAPORIN-2 INCREASED WATER PERMEABILITY OF COLLECTING DUCT WATER RETENTION